 But sometimes progress gets slowed down by things like disease because it's hard to get out and actually do clinical trials. And this isn't just for the AMD research. It's a lot of different things in medicine. So, you know, good news and bad news about COVID. Let's take a few calls here, George. We've still got lots to talk with you about. Let's start with Cheryl in Seattle, Washington. Welcome, Cheryl. Hi, guys. Thanks for having me on. You're welcome. Thanks for calling and go ahead.